Mehrul Hasnain

Summary

Publications

  1. doi request reprint QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review
    Mehrul Hasnain
    Department of Psychiatry, Memorial University, St John s, NL, Canada
    CNS Drugs 28:887-920. 2014
  2. ncbi request reprint Possible role of vascular risk factors in Alzheimer's disease and vascular dementia
    Mehrul Hasnain
    Waterford Hospital, St John s, NL A1E 4J8, Canada
    Curr Pharm Des 20:6007-13. 2014
  3. doi request reprint Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians
    Mehrul Hasnain
    Department of Psychiatry, Memorial University, St John s, Newfoundland, Canada
    Postgrad Med 124:154-67. 2012
  4. doi request reprint Psychosis in Parkinson's disease: therapeutic options
    M Hasnain
    Department of Psychiatry, Memorial University of Newfoundland, St John s, Newfoundland, Canada
    Drugs Today (Barc) 47:353-67. 2011
  5. doi request reprint Depression screening in patients with coronary heart disease: a critical evaluation of the AHA guidelines
    Mehrul Hasnain
    Department of Psychiatry, Memorial University of Newfoundland, St John s, Newfoundland, Canada
    J Psychosom Res 71:6-12. 2011
  6. doi request reprint Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs
    Mehrul Hasnain
    Department of Psychiatry, Memorial University of Newfoundland, St John s, NL, Canada
    J Psychopharmacol 25:715-21. 2011
  7. doi request reprint Metabolic syndrome associated with schizophrenia and atypical antipsychotics
    Mehrul Hasnain
    Department of Psychiatry, Sir Thomas Roddick Hospital, Stephenville, NL, Canada
    Curr Diab Rep 10:209-16. 2010
  8. doi request reprint Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions
    Mehrul Hasnain
    Department of Psychiatry, Western Regional Integrated Health Authority, Sir Thomas Roddick Hospital, Stephenville, Newfoundland, Canada
    CNS Drugs 24:193-206. 2010
  9. doi request reprint Pharmacological management of psychosis in elderly patients with parkinsonism
    Mehrul Hasnain
    Department of Psychiatry, Western Regional Integrated Health Authority, Sir Thomas Roddick Hospital, Stephenville, Newfoundland, Canada
    Am J Med 122:614-22. 2009
  10. doi request reprint Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications
    Mehrul Hasnain
    Department of Psychiatry, Western Regional Integrated Health Authority, Sir Thomas Roddick Hospital, Stephenville, Newfoundland, Canada
    Prim Care Diabetes 3:5-15. 2009

Detail Information

Publications11

  1. doi request reprint QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review
    Mehrul Hasnain
    Department of Psychiatry, Memorial University, St John s, NL, Canada
    CNS Drugs 28:887-920. 2014
    ..Future research needs to improve its precision and broaden its scope to better understand the factors that facilitate or attenuate progression of drug-associated QTc interval prolongation to TdP...
  2. ncbi request reprint Possible role of vascular risk factors in Alzheimer's disease and vascular dementia
    Mehrul Hasnain
    Waterford Hospital, St John s, NL A1E 4J8, Canada
    Curr Pharm Des 20:6007-13. 2014
    ....
  3. doi request reprint Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians
    Mehrul Hasnain
    Department of Psychiatry, Memorial University, St John s, Newfoundland, Canada
    Postgrad Med 124:154-67. 2012
    ..We recommend that all patients taking SGADs be screened using anthropometric measures and metabolic assessment at baseline. Monitoring should be guided individually based on weight gain and other risk factors...
  4. doi request reprint Psychosis in Parkinson's disease: therapeutic options
    M Hasnain
    Department of Psychiatry, Memorial University of Newfoundland, St John s, Newfoundland, Canada
    Drugs Today (Barc) 47:353-67. 2011
    ..Future research should ensure sound methodological quality and control for confounding variables to provide results that could be used reliably in clinical practice...
  5. doi request reprint Depression screening in patients with coronary heart disease: a critical evaluation of the AHA guidelines
    Mehrul Hasnain
    Department of Psychiatry, Memorial University of Newfoundland, St John s, Newfoundland, Canada
    J Psychosom Res 71:6-12. 2011
    ..This lack has challenged the advisory issued by the American Heart Association (AHA) to routinely screen for depression in CHD patients. We assess the AHA advisory in the context of well-established criteria of screening for diseases...
  6. doi request reprint Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs
    Mehrul Hasnain
    Department of Psychiatry, Memorial University of Newfoundland, St John s, NL, Canada
    J Psychopharmacol 25:715-21. 2011
    ..Metformin therapy should not preclude healthy lifestyle interventions...
  7. doi request reprint Metabolic syndrome associated with schizophrenia and atypical antipsychotics
    Mehrul Hasnain
    Department of Psychiatry, Sir Thomas Roddick Hospital, Stephenville, NL, Canada
    Curr Diab Rep 10:209-16. 2010
    ....
  8. doi request reprint Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions
    Mehrul Hasnain
    Department of Psychiatry, Western Regional Integrated Health Authority, Sir Thomas Roddick Hospital, Stephenville, Newfoundland, Canada
    CNS Drugs 24:193-206. 2010
    ..Further long-term studies are needed to extend our observations and improve this strategy...
  9. doi request reprint Pharmacological management of psychosis in elderly patients with parkinsonism
    Mehrul Hasnain
    Department of Psychiatry, Western Regional Integrated Health Authority, Sir Thomas Roddick Hospital, Stephenville, Newfoundland, Canada
    Am J Med 122:614-22. 2009
    ..We focus on the pharmacologic management of psychosis with atypical antipsychotic medications and briefly review the role of acetylcholinesterase inhibitors...
  10. doi request reprint Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications
    Mehrul Hasnain
    Department of Psychiatry, Western Regional Integrated Health Authority, Sir Thomas Roddick Hospital, Stephenville, Newfoundland, Canada
    Prim Care Diabetes 3:5-15. 2009
    ..In this article, we review the metabolic profile of atypical antipsychotic medications and offer guidelines to reduce the metabolic complications of these agents...
  11. doi request reprint The risk of overweight in children and adolescents with major mental illness
    Mehrul Hasnain
    Department of Psychiatry, Western Regional Integrated Health Authority, Sir Thomas Roddick Hospital, Newfoundland, Canada
    South Med J 101:367-72. 2008
    ..To survey the charts of youths with major mental illness who may constitute a high-risk group (HRG) for overweight...